Hyperprogressive Disease in Lung Cancer with Transformation of Adenocarcinoma to Small-cell Carcinoma during Pembrolizumab Therapy

Hyperprogressive disease (HPD) is a paradoxical phenomenon involving the acceleration of tumor progression after treatment with immune checkpoint inhibitors (ICIs). A 66-year-old male smoker with advanced lung adenocarcinoma started pembrolizumab for progressive disease following first-line chemothe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Intern Med
Hlavní autoři: Okeya, Komugi, Kawagishi, Yukio, Muranaka, Emiri, Izumida, Toshihide, Tsuji, Hiroshi, Takeda, Shinichi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Japanese Society of Internal Medicine 2019
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6911749/
https://ncbi.nlm.nih.gov/pubmed/31327828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2892-19
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky